Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. (Q35866971)
Jump to navigation
Jump to search
scientific article published in April 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. |
scientific article published in April 2012 |
Statements
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting (English)
Josef Singer
Marlene Weichselbaumer
Diana Mechtcheriakova
Yury Sobanov
Erika Bajna
Friedrich Wrba
Reinhard Horvat
Johann G Thalhammer